Feature | Ventricular Assist Devices (VAD) | May 05, 2017

FDA, Medtronic Expand HeartWare VAD Recall, Announces New Recall of VAD Component

Recall includes Heartware controllers, DC adapter driveline repair splice kit

Heartware HVAD recall for its ventricular assist device from Medtronic

May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist Device (HVAD) system to include an additional product code and instructions to exchange recalled products. The company originally recalled the VAD system in November 2016 recall due to issues with its controller and power connector issues. Additionally, Medtronic announced a new related recall for the HeartWare splice kit intended to repair the HVAD driveline because it may cause electrical issues or stop the pump. FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

The company recalled the HVAD controller due to a loose power connector which may cause the rear portion of the pump’s driveline connector to become separated from the front portion of the driveline connector. A loose connector may allow moisture to enter the controller causing corrosion, electrical issues, reduced speaker volume and connection failures. If the speaker volume is decreased, the patient may not hear the alarm. If there is a loss of connection, the pump may stop, which could cause serious adverse health consequences, including death, the U.S. Food and Drug Administration (FDA) said in the recall alert.

Since the issuance of the November 2016 recall, Medtronic Mechanical Circulatory Support has developed an updated HVAD controller and power management software to address the power connector issues.

The issue include all heartWare controllers. This includes product codes: 1400, 1401, 1403, 1407 and the additional code 1435 for the HVAD DC adapter.  These were manufactured between March 1, 2006 to Dec. 1, 2016 and were distributed between Oct. 11, 2006 to Dec. 1, 2016.

The HeartWare VAD helps deliver blood from the heart to the rest of the body. It is used in patients who are at risk of death from end-stage left ventricular heart failure and who are waiting for a heart transplant.

Recommendations to Hospitals

Medtronic and the FDA said facilities should review the notice and forms, and forward the notice to other staff within their organizations for their awareness. They should then complete, sign and return the acknowledgement form to Medtronic Mechanical Circulatory Support within 30 days of receipt of the letter.

Complete training that will cover the new product labeling including the instructions for use and patient manual.

Hospitals should quarantine and replace affected HVAD controllers, DC adapters, instructions for use, emergency responder guides and patient manuals in hospital inventory after training is complete. These items should be returned to Medtronic. Once the affected product in inventory has been identified and returned, complete and return the “completion form” and send to [email protected] or the Medtronic Mechanical Circulatory Support representative no later than 12 months from the date of the letter according to the instructions on the form.

They also should notify and schedule each of their patients as soon as possible for an appointment to exchange their controllers.

 

New HVAD Driveline Splice Kit Recall

Medtronic announced March 10 it is recalling the driveline splice kit due to a design problem that would prevent the repaired cable assembly from withstanding excessive force or pull (e.g. accidental dropping of controllers or snagging driveline cables). The excessive force or pull could cause damage to the cable assembly and interrupt electrical connection. The company issued these kits between April 2010 and March 2015 to repair previous HVAD driveline cable connector assembly issues. 

An interruption in electrical connection may cause the pump to stop, which may lead to serious adverse health consequences, including death.

The recall includes all driveline splice repair kits that were used prior to April 2015 includes product codes ASY00116 and ASY00281. These were distributed between Jan. 11, 2011 to May 23, 2014. This includes 9 devices in the U.S.

HeartWare VAD Use

The HVAD helps deliver blood from the heart to the rest of the body. It is used in patients who are at risk of death from end-stage left ventricular heart failure and who are waiting for a heart transplant. The system includes a pump implanted in the space around the heart (pericardium). It also includes a driveline cable that goes through the skin. The driveline connects the pump to an external controller that regulates the speed and function of the pump. The system is powered with batteries or power adapters. The HVAD is designed for use both in and out of hospital settings, including during patient transport.
The driveline splice kit is intended to repair the driveline once an electrical break has been identified. These repairs are limited to the section of the driveline that is outside of the patient.

Link to the FDA recalls page “2017 Medical Device Recalls."
 

Read the MedWatch safety alert, including a link to the FDA Recall Notice.

Related Content

Michigan Hospital Improves Post-CABG Outcomes Using Proactive Amiodarone Protocol
News | Cardiovascular Surgery | October 23, 2019
Proactive administration of amiodarone to patients recovering from a common heart surgery shows promise in preventing...
Gore Block Grant Supports SVS Quality Programs
News | Cardiovascular Surgery | October 17, 2019
W. L. Gore & Associates Inc. will support a new Society for Vascular Surgery (SVS) initiative to advance patient...
Heart and Lung Surgery Patients May Be at High Risk for Opioid Dependence

Image courtesy of the American Heart Association

News | Cardiovascular Surgery | August 22, 2019
The amount of opioids prescribed for patients after heart and lung surgery has a direct relationship with the risk for...
Keck School of Medicine Promotes Patient Diversity in Cardiac Surgery Clinical Trials
News | Cardiovascular Surgery | July 26, 2019
A highly competitive $4.5 million grant from the National Institutes of Health (NIH) National Heart, Lung and Blood...
Google Doodle Celebrates Coronary Artery Bypass Graft Pioneer René Favaloro
News | Cardiovascular Surgery | July 12, 2019 | Jeff Zagoudis, Associate Editor
Internet search engine giant Google unveiled a new Doodle on its homepage Friday, July 12, celebrating the life and...
Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease
News | Cardiovascular Surgery | May 03, 2019
Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one...
SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Overlay Init